Asthma & ABPA Pre-Screening Study
Research type
Research Study
Full title
A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients with Asthma
IRAS ID
329975
Contact name
Rory Taylor
Contact email
Sponsor organisation
Pulmatrix Inc
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 7 months, 5 days
Research summary
This prescreening study is to diagnose Allergic Bronchpulmonary Aspergillosis (ABPA)in selected patients with asthma. In turn, this will increase the potential number of eligible participants for an ongoing study (IRAS 1006803) investigating an inhaler for ABPA sufferers.
Participants involvement in the study will only last for between 2-4 weeks.
The study's aiming to recruit patients over the age of 18 who have a diagnosis of asthma and have had at least one exacerbation that required treatment in the last 10 months.
REC name
Wales REC 7
REC reference
23/WA/0277
Date of REC Opinion
21 Dec 2023
REC opinion
Further Information Favourable Opinion